At the Packard Symposium sponsored by Johns Hopkins, Dr. Smith discussed the preliminary results from the ongoing Nuedexta treatment trials as it relates to the assessment of bulbar function in ALS trials.
top of page
News
At the California ALS Summit held at the Gladstone Institute in San Francisco, Dr. Smith served on a panel that focused on translational medicine and presented an overview of his work on the assessment of speech and swallowing in ALS trials.
Dr. Smith discussed the assessment of bulbar function in ALS clinical trials at Biogen Pharmaceuticals (Boston), at the ALS Investigator Research Workshop sponsored by ALSA (Philadelphia), and again in Clearwater, Florida at the NEALS annual meeting.
bottom of page